MedPath

JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMET L.L.C.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Otherwise Healthy Obese Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2012-12-25
Last Posted Date
2018-12-13
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
80
Registration Number
NCT01756404

A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Oral contraceptive
First Posted Date
2012-10-25
Last Posted Date
2012-11-19
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
30
Registration Number
NCT01714193

A Study of ULTRAM ER at Two Dose Levels in Adolescents With Pain

Phase 1
Completed
Conditions
Pain
Interventions
First Posted Date
2012-04-26
Last Posted Date
2012-08-29
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
38
Registration Number
NCT01586507

A Pharmacokinetic, Tolerability, and Safety Study of ULTRAM ER in Children With Pain

Phase 1
Completed
Conditions
Pain
Interventions
First Posted Date
2012-04-26
Last Posted Date
2012-08-29
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
37
Registration Number
NCT01586494

A Pharmacokinetic Study to Characterize JNJ-39393406 in the Cerebrospinal Fluid of Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: Placebo
First Posted Date
2012-03-16
Last Posted Date
2013-07-24
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
12
Registration Number
NCT01556217

Risk of Shopping Behavior of Tapentadol Immediate-Release (IR) Compared to Oxycodone Immediate-Release (IR)

Completed
Conditions
Substance Abuse Detection
Interventions
First Posted Date
2012-03-07
Last Posted Date
2012-10-29
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
646620
Registration Number
NCT01545778
© Copyright 2025. All Rights Reserved by MedPath